Results 141 to 150 of about 181,344 (173)

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10). [PDF]

BMJ Open
Ozaki Y, Koyama S, Morita S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, Tamaki K, Ishiguro H, Saji S, Miwa A, Matsunaga J, Zheng Y, Nishikawa H, Masuda N.   +19 more
europepmc   +1 more source

Modulating the tumor immune phenotypes by radiotherapy: formulating and validating the combination therapy of radiation, PD-L1, and TIM-3 blockade in colorectal cancer. [PDF]

J Immunother Cancer
Wang XX, Zhu C, Sun Y, Xie X, Wang M, Jin Y, Gu Y, Qian L, Shi L, Xu J, Wang F, Huang X, Dai S, Sun X.   +13 more
europepmc   +1 more source

Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma. [PDF]

J Immunother Cancer
Zhu Y, Liu M, Fan X, Xu Y, Diao X, Bi J, Wan X, Assaraf YG, Kwok HF, Chen L.   +9 more
europepmc   +1 more source

Exploratory characterization of dynamic soluble programmed death-ligand 1 trajectories and their association with mortality in critical coronavirus disease 2019. [PDF]

J Intensive Care
Takeuchi S, Kawamoto E, Matsusaki T, Ono D, Sakakura Y, Gaowa A, Park EJ, Shimaoka M, Kaku R.   +8 more
europepmc   +1 more source

Selective targeting of apoptotic pathways in follicular lymphoma cells [PDF]

Wlodkowic, Donald
core  

Cadonilimab plus chemotherapy <i>vs</i>. PD-1 inhibitor plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction cancer with PD-L1 combined positive score <5: a propensity-matched, retrospective cohort study. [PDF]

J Gastrointest Oncol
Zhao D, Wu Z, Huang Y, Zhang L, Yuan X, Zhang N, Wei Q, Li J, Ying J, Xu Q.   +9 more
europepmc   +1 more source

Development and Validation of a Multicyclic Peptide Targeting PD-L1 for Radiotheranostics. [PDF]

ACS Med Chem Lett
Meng L, Li X, Patel JS, Liang SH.
europepmc   +1 more source

In search of novel PD1 inhibitor from natural products by high-throughput virtual screening and molecular dynamics simulation. [PDF]

PLoS One
Sharma N, Debnath A, Mazumder R, Rai P, Singh RK.   +4 more
europepmc   +1 more source